
TherapeuticsMD Inc (NASDAQ:TXMD) is trading higher Monday after the company announced it would sell its prescription services business, vitaCare, to GoodRx Holdings Inc (NASDAQ:GDRX).
Under terms of the agreement, TherapeuticsMD will receive $150 million in cash with up to an additional $7 million in cash consideration contingent upon vitaCare’s financial performance through 2023. The transaction is expected to close in the second quarter.